Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Nutradeica is a topical facial gel-cream developed by ISDIN S.A. for the management of seborrheic dermatitis of the face and chest. Classified as a cosmeceutical, it is intended as an adjuvant to pharmacological treatments to address excess sebum, flaking, itching, and erythema. Its formulation includes piroctone olamine for antifungal activity against *Malassezia* yeast, zinc pidolate for sebum regulation, acetamide MEA for kerato-regulation, and anti-inflammatory agents such as stearyl glycyrrhetinate and Rhamnosoft. The product is designed with an oil-free, non-comedogenic, and mattifying texture to ensure rapid absorption and patient compliance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Nutradeica (ISDIN).